TAUROKINASE Trademark

Trademark Overview

On Friday, March 5, 2021, a trademark application was filed for TAUROKINASE with the United States Patent and Trademark Office. The USPTO has given the TAUROKINASE trademark a serial number of 79311887. The federal status of this trademark filing is REGISTERED as of Tuesday, July 5, 2022. This trademark is owned by TauroPharm GmbH. The TAUROKINASE trademark is filed in the Pharmaceutical Products category with the following description:

Medical preparations containing recombinant, fibrinolytically active urokinase or consisting thereof, in particular for use in combination with taurolidine-containing catheter lock solutions
taurokinase

General Information

Serial Number79311887
Word MarkTAUROKINASE
Filing DateFriday, March 5, 2021
Status700 - REGISTERED
Status DateTuesday, July 5, 2022
Registration Number6776841
Registration DateTuesday, July 5, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesMedical preparations containing recombinant, fibrinolytically active urokinase or consisting thereof, in particular for use in combination with taurolidine-containing catheter lock solutions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTauroPharm GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameTauroPharm GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameTauroPharm GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Saturday, October 15, 2022FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 15, 2022FINAL DISPOSITION PROCESSED
Wednesday, October 5, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 5, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 5, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 3, 2022NOTIFICATION PROCESSED BY IB
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 13, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 14, 2022ASSIGNED TO LIE
Friday, March 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 15, 2021REFUSAL PROCESSED BY IB
Monday, October 25, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 25, 2021REFUSAL PROCESSED BY MPU
Wednesday, October 6, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 5, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 28, 2021ASSIGNED TO EXAMINER
Saturday, June 5, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, June 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 27, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

taurokinase containing combination particular taurolidine lock solutions thereof catheter consisting recombinant